Glial modulating and neurotrophic properties of propentofylline and its application to Alzheimer's disease and vascular dementia.
Ringheim
G E
GE
Department of Neuroscience, Aventis Pharmaceuticals, Inc., Bridgewater, New Jersey 08807, USA. garth.ringheim@Aventis.com
D000544:Alzheimer Disease / Q000188:drug therapy*; D000818:Animals; D015140:Dementia, Vascular / Q000188:drug therapy*; D006801:Humans; D007858:Learning / Q000187:drug effects; D008568:Memory / Q000187:drug effects; D009457:Neuroglia / Q000187:drug effects*; D018696:Neuroprotective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D014970:Xanthines / Q000494:pharmacology / Q000627:therapeutic use*
D018696:Neuroprotective Agents; D014970:Xanthines; C032114:propentofylline